These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 29150948

  • 1. Methylation-associated DOK1 and DOK2 down-regulation: Potential biomarkers for predicting adverse prognosis in acute myeloid leukemia.
    He PF, Xu ZJ, Zhou JD, Li XX, Zhang W, Wu DH, Zhang ZH, Lian XY, Yao XY, Deng ZQ, Lin J, Qian J.
    J Cell Physiol; 2018 Sep; 233(9):6604-6614. PubMed ID: 29150948
    [Abstract] [Full Text] [Related]

  • 2. DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia.
    Sun GK, Tang LJ, Zhou JD, Xu ZJ, Yang L, Yuan Q, Ma JC, Liu XH, Lin J, Qian J, Yao DM.
    Cancer Med; 2019 Oct; 8(14):6393-6402. PubMed ID: 31486300
    [Abstract] [Full Text] [Related]

  • 3. Decreased SCIN expression, associated with promoter methylation, is a valuable predictor for prognosis in acute myeloid leukemia.
    Zhang ZH, Zhang W, Zhou JD, Zhang TJ, Ma JC, Xu ZJ, Lian XY, Wu DH, Wen XM, Deng ZQ, Lin J, Qian J.
    Mol Carcinog; 2018 Jun; 57(6):735-744. PubMed ID: 29457658
    [Abstract] [Full Text] [Related]

  • 4. Hypermethylation of ITGBL1 is associated with poor prognosis in acute myeloid leukemia.
    Lian XY, Ma JC, Zhou JD, Zhang TJ, Wu DH, Deng ZQ, Zhang ZH, Li XX, He PF, Yan Y, Lin J, Qian J.
    J Cell Physiol; 2019 Jun; 234(6):9438-9446. PubMed ID: 30317626
    [Abstract] [Full Text] [Related]

  • 5. Methylation-independent ITGA2 overexpression is associated with poor prognosis in de novo acute myeloid leukemia.
    Lian XY, Zhang W, Wu DH, Ma JC, Zhou JD, Zhang ZH, Wen XM, Xu ZJ, Lin J, Qian J.
    J Cell Physiol; 2018 Dec; 233(12):9584-9593. PubMed ID: 30132837
    [Abstract] [Full Text] [Related]

  • 6. DLX4 hypermethylation is a prognostically adverse indicator in de novo acute myeloid leukemia.
    Zhou JD, Zhang TJ, Wang YX, Yang DQ, Yang L, Ma JC, Wen XM, Yang J, Lin J, Qian J.
    Tumour Biol; 2016 Jul; 37(7):8951-60. PubMed ID: 26753961
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia.
    Tao YF, Fang F, Hu SY, Lu J, Cao L, Zhao WL, Xiao PF, Li ZH, Wang NN, Xu LX, Du XJ, Sun LC, Li YH, Li YP, Xu YY, Ni J, Wang J, Feng X, Pan J.
    BMC Cancer; 2015 Oct 21; 15():756. PubMed ID: 26490736
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Zinc finger protein 382 is downregulated by promoter hypermethylation in pediatric acute myeloid leukemia patients.
    Tao YF, Hu SY, Lu J, Cao L, Zhao WL, Xiao PF, Xu LX, Li ZH, Wang NN, Du XJ, Sun LC, Zhao H, Fang F, Su GH, Li YH, Li YP, Xu YY, Ni J, Wang J, Feng X, Pan J.
    Int J Mol Med; 2014 Dec 21; 34(6):1505-15. PubMed ID: 25319049
    [Abstract] [Full Text] [Related]

  • 12. Differential role of Dok1 and Dok2 in TLR2-induced inflammatory signaling in glia.
    Downer EJ, Johnston DG, Lynch MA.
    Mol Cell Neurosci; 2013 Sep 21; 56():148-58. PubMed ID: 23659921
    [Abstract] [Full Text] [Related]

  • 13. The 5' flanking region of miR-378 is hypomethylated in acute myeloid leukemia.
    Zhu XW, Wen XM, Zhang YY, Yang L, Guo H, Yang J, Zhang M, Yin JY, Ma JC, Lin J, Deng ZQ, Qian J.
    Int J Clin Exp Pathol; 2015 Sep 21; 8(5):4321-31. PubMed ID: 26191124
    [Abstract] [Full Text] [Related]

  • 14. Prognostic role of DOK family adapters in acute myeloid leukemia.
    Zhang L, Li R, Hu K, Dai Y, Pang Y, Jiao Y, Liu Y, Cui L, Shi J, Cheng Z, Fu L.
    Cancer Gene Ther; 2019 Sep 21; 26(9-10):305-312. PubMed ID: 30348947
    [Abstract] [Full Text] [Related]

  • 15. Dok1 and Dok2 Proteins Regulate Cell Cycle in Hematopoietic Stem and Progenitor Cells.
    Coppin E, De Grandis M, Pandolfi PP, Arcangeli ML, Aurrand-Lions M, Nunès JA.
    J Immunol; 2016 May 15; 196(10):4110-21. PubMed ID: 27183638
    [Abstract] [Full Text] [Related]

  • 16. Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer.
    Mercier PL, Bachvarova M, Plante M, Gregoire J, Renaud MC, Ghani K, Têtu B, Bairati I, Bachvarov D.
    Mol Oncol; 2011 Oct 15; 5(5):438-53. PubMed ID: 21856257
    [Abstract] [Full Text] [Related]

  • 17. Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia.
    Xu ZJ, Ma JC, Zhou JD, Wen XM, Yao DM, Zhang W, Ji RB, Wu DH, Tang LJ, Deng ZQ, Qian J, Lin J.
    J Transl Med; 2019 Mar 29; 17(1):102. PubMed ID: 30922328
    [Abstract] [Full Text] [Related]

  • 18. Abnormal expression and methylation of PRR34-AS1 are associated with adverse outcomes in acute myeloid leukemia.
    Nan FY, Gu Y, Xu ZJ, Sun GK, Zhou JD, Zhang TJ, Ma JC, Leng JY, Lin J, Qian J.
    Cancer Med; 2021 Aug 29; 10(15):5283-5296. PubMed ID: 34227248
    [Abstract] [Full Text] [Related]

  • 19. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
    Tao YF, Xu LX, Lu J, Hu SY, Fang F, Cao L, Xiao PF, Du XJ, Sun LC, Li ZH, Wang NN, Su GH, Li YH, Li G, Zhao H, Li YP, Xu YY, Zhou HT, Wu Y, Jin MF, Liu L, Zhu XM, Ni J, Wang J, Xing F, Zhao WL, Pan J.
    J Exp Clin Cancer Res; 2015 Jan 22; 34(1):4. PubMed ID: 25609158
    [Abstract] [Full Text] [Related]

  • 20. Downstream of tyrosine kinase 1 and 2 play opposing roles in CD200 receptor signaling.
    Mihrshahi R, Brown MH.
    J Immunol; 2010 Dec 15; 185(12):7216-22. PubMed ID: 21078907
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.